Trinity Innovation Fund

Xingshen Zhineng is a supplier of smart logistics products and a provider of unmanned driving core technology. It has full-stack independent research and development and design capabilities ranging from chassis, structure, hardware, and software to unmanned driving technology and solutions. Xingshen Intelligent has independently developed the Chaoying, Fanyu, Benxiao, Jedi, and Buyi series of unmanned vehicle products based on independent and controllable software and hardware technologies. The company has introduced a line of unmanned vehicle products suitable for a variety of terminal logistics application scenarios, as well as unmanned driving kits for automatic driving models such as sweepers, inspection vehicles, and unmanned buses.

Epigenic Therapeutics is a biotechnology company focused on developing gene editing therapies that leverage gene-silencing technology to address a range of diseases. The firm specializes in epigenome editing, aiming to regulate various conditions, including those related to ophthalmology, neurodegeneration, metabolism, and rare diseases. By creating innovative treatments, Epigenic Therapeutics seeks to offer effective solutions for patients suffering from chronic and severe health issues.

Aijie Boya is a medical instrument and magnetic solid-phase material company.

Bluepha specializes in synthetic biotechnology, aiming to innovate microbial manufacturing and material development. The company integrates bioengineering and data science to create bio-based products that cater to various industries, including consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By focusing on research and development, Bluepha applies synthetic biology to optimize cellular processes and develop new bio-manufacturing products, allowing clients to assemble and enhance products through engineered biological materials. This approach enables significant advancements in product innovation and efficiency across multiple sectors.

HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.

Bluepha specializes in synthetic biotechnology, aiming to innovate microbial manufacturing and material development. The company integrates bioengineering and data science to create bio-based products that cater to various industries, including consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By focusing on research and development, Bluepha applies synthetic biology to optimize cellular processes and develop new bio-manufacturing products, allowing clients to assemble and enhance products through engineered biological materials. This approach enables significant advancements in product innovation and efficiency across multiple sectors.

XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders. Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of their mitochondria-targeting platform.

Dizal Pharmaceutical is a research-based biotechnology company dedicated to the discovery, development, and commercialization of first-in-class/best-in-class medicines.

Bluepha specializes in synthetic biotechnology, aiming to innovate microbial manufacturing and material development. The company integrates bioengineering and data science to create bio-based products that cater to various industries, including consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By focusing on research and development, Bluepha applies synthetic biology to optimize cellular processes and develop new bio-manufacturing products, allowing clients to assemble and enhance products through engineered biological materials. This approach enables significant advancements in product innovation and efficiency across multiple sectors.